Free Trial
NASDAQ:PETS

PetMed Express Q4 2025 Earnings Results & Report

PetMed Express logo
$1.06 -0.15 (-11.98%)
Closing price 11/11/2026 04:00 PM Eastern
Extended Trading
$1.13 +0.06 (+5.92%)
As of 04:39 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

PetMed Express missed analyst earnings expectations in its Q4 2025 results, released October 14, 2025. The company reported EPS of -$0.56 versus the $0.04 consensus estimate, while revenue was $46.47 million.

Earnings Announcement Details

Quarter
Q4 2025
Report Date
Time
Before Market Opens
Conference Call
4:00 PM ET

PetMed Express EPS Results

Actual EPS
-$0.56
Consensus EPS
$0.04
Beat/Miss
Missed by -$0.60
One Year Ago EPS
N/A
EPS Beat Rate
2 of last 8 quarters

PetMed Express Revenue Results

Actual Revenue
$46.47 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

PetMed Express Q4 2025 Earnings FAQ

PetMed Express (NASDAQ:PETS) reported earnings of -$0.56 per share for Q4 2025, missing the consensus estimate of $0.04. The report was announced on Tuesday, October 14, 2025.

PetMed Express reported revenue of $46.47 million for Q4 2025.

PetMed Express Earnings Headlines

PetMed Express Q2 2027 Earnings Call Transcript
I'm handing you this one free
Elon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds. He licenses it from one overlooked company. That supplier just got a major catalyst. Musk filed to launch 1,000,000 satellites, a move analyst Dylan believes could drive a 100X bigger bill for this chipmaker starting December 8th.tc pixel
PetMeds® Announces Second Quarter Financial Results
PetMed Express Q2 earnings preview
See More PetMed Express Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like PetMed Express? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PetMed Express and other key companies, straight to your email.

About PetMed Express

PetMed Express (NASDAQ:PETS), doing business as PetMeds, is an online retailer of prescription and nonprescription medications and health products for dogs, cats and other household pets. The company offers products used to treat or prevent conditions such as allergies, infections, parasites and chronic illnesses, including prescription medicines, flea and tick treatments, heartworm preventatives, supplements and other animal-health products.

In addition to medications, PetMeds sells pet food, treats, vitamins, wellness products and selected supplies. Customers can place orders through the company’s website and other direct-to-consumer channels, with prescription orders generally requiring authorization from a licensed veterinarian. PetMeds primarily serves pet owners in the United States.

Founded in 1996 and previously known as 1-800-PetMeds, the company has built its business around convenient home delivery and consumer access to pet-health products. PetMed Express is headquartered in Delray Beach, Florida, and its common stock trades on the Nasdaq Capital Market under the symbol PETS.

View PetMed Express Profile